Schreiber to Receive Cancer Immunology Research Award
Robert Schreiber, PhD
March 5, 2014 – Robert Schreiber, PhD, director of the Center for Human Immunology and Immunotherapy Programs at Washington University School of Medicine, will receive the second annual Lloyd J. Old Award in Cancer Immunology from the American Association for Cancer Research and Cancer Research Institute.
Schreiber, who also is the Alumni Professor of Pathology and Immunology and a professor of molecular microbiology, is being recognized for his contributions to the field of cancer immunology, which have helped establish a clearer understanding of how cancer evades detection by the immune system.
The award will be presented to Schreiber at the American Association for Cancer Research annual meeting April 5-9 in San Diego. As part of the honor, Schreiber will discuss cancer immunoediting, a process he discovered in which the immune system protects against tumor development and shapes cancers that form.
“I am tremendously honored to receive this recognition from AACR and CRI. This award is particularly meaningful to me because it bears the name of Lloyd J. Old, who so significantly influenced the course of my career by getting me interested in the field of cancer immunology,” Schreiber said. “It is indeed a very exciting time to be working in this area of research and to see some of that work translated by others into novel and effective cancer immunotherapies. I am grateful to the large number of talented young investigators who contributed their efforts to the development of our research program over the years and to the many colleagues, both at Washington University School of Medicine in St. Louis and elsewhere, who provided indispensable advice and support for our efforts.”
Schreiber received his doctorate from the State University of New York at Buffalo and completed his postdoctoral training at the Scripps Institute in La Jolla, Calif., where he served on the faculty before joining Washington University in 1985.
The Lloyd J. Old award was established in 2013 to recognize cancer immunologists who, like the late Lloyd J. Old, have conducted innovative research in cancer immunology and that has had a far-reaching impact on the field.